Patents by Inventor Lily Zou

Lily Zou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Feline immunodeficiency virus nucleotide sequence
    Patent number: 6579527
    Abstract: This invention relates to a highly cytopathic and infectious clone constructed from the genomic DNA of a cat FIV. The nucleotide sequences of the infectious clone is disclosed. The nucleotide sequence, and peptides derived therefrom can be used in the detection of, and protection against FIV in both domestic and nondomestic cats. Further, chimeric viruses having the desired immunologic and pathogenic properties can be constructed.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: June 17, 2003
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Margaret C. Barr, Roger J. Avery, Claudia A. Sutton, Fan Long, Lily Zou
  • Inhibition of LERK-2-mediated cell adhesion
    Patent number: 6514497
    Abstract: Methods of modulating LERK-2-mediated cell adhesion, as well as methods of modulating angiogenesis and inflammation are described. Also described are agents such as antibodies which can modulate LERK-2-mediated cell adhesion, as well as methods of treating angiogenic diseases and inflammatory diseases.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: February 4, 2003
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Michael J. Briskin, Lily Zou
  • Novel feline immunodeficiency virus nucleotide sequence
    Publication number: 20020044945
    Abstract: This invention relates to a highly cytopathic and infectious clone constructed from the genomic DNA of a cat FIV. The nucleotide sequences of the infectious clone is disclosed. The nucleotide sequence, and peptides derived therefrom can be used in the detection of, and protection against FIV in both domestic and nondomestic cats. Further, chimeric viruses having the desired immunologic and pathogenic properties can be constructed.
    Type: Application
    Filed: September 4, 2001
    Publication date: April 18, 2002
    Inventors: Margaret C. Barr, Roger J. Avery, Claudia A. Sutton, Fan Long, Lily Zou